Send me a link:

*Text messaging rates may apply.

 Dow Down 0.16% Nasdaq Up 0.40%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM
1.57 0.06(3.38%) Jul 23, 4:00PM EDT
Prev Close:1.63
Open:1.64
Bid:0.96 x 200
Ask:1.69 x 300
1y Target Est:4.17
Beta:0.6
Earnings Date:Sep 8 - Sep 12 (Est.)
Day's Range:1.55 - 1.67
52wk Range:1.16 - 3.18
Volume:2,256,196
Avg Vol (3m):1,246,170
Market Cap:281.36M
P/E (ttm):N/A
EPS (ttm):-0.22
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PPHM

Comparison

Symbol% ChgMkt Cap
PPHMDown 3.38%281.36M
AMGN92.36B
NVS215.98B
RHHBY250.09B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.00
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Apr-15) :-0.27
Quarterly EPS Est (Jul-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the research and development of novel monoclonal antibodies for the treatment and diagnosis of cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback